Healthcare
-
Opinion: Medical debt is holding Pennsylvanians back. But relief is on the ballot.
In this op-ed, Corei Flowers, Fundraising Director of Debtless, highlights how rising consumer and medical debt in Pennsylvania is eroding financial freedom and argues for systemic debt cancellation to boost economic recovery.
-
Harris seeks to lower drug costs for Pennsylvanians, building on recent progress
Harris wants to expand the $35 monthly cap on insulin costs and a $2,000 annual cap on out-of-pocket drug costs so that they apply to all Americans, not just seniors on Medicare.
-
Everything you need to know about the new flu and COVID vaccines
When it comes to protection against flu and COVID, vaccines are necessary to tackle the latest strains of each. Here’s what you need to know.
-
Doctors say the ‘Inflation Reduction Act’ has been a success story in Pennsylvania
Here’s how a single policy from the Biden-Harris administration saved hundreds of thousands of Pennsylvanians money every month.
-
After expanding health care access for Pennsylvanians, Harris has new plan to cut costs further
After casting the tie-breaking vote for the Inflation Reduction Act, Vice President Kamala Harris is proposing to expand capping the cost of insulin at $35 and prescription drug costs at $2,000 for all Americans.
-
Lancaster Dems praise Inflation Reduction Act’s lowering of prescription drug costs
Lancaster County Democrats celebrated the two-year anniversary of the Inflation Reduction Act on Friday. The landmark legislation has helped millions of Pa. residents with lower prescription drug costs and more.
-
Biden-Harris administration’s Medicare drug price negotiations secure $6 billion in savings for taxpayers
The White House estimates that these new prices will lead to around $6 billion in savings for the Medicare program in 2026. The new prices will be anywhere from 38% to 79% lower than the drugs’ list prices last year, saving seniors on Medicare an estimated $1.5 billion in out-of-pocket costs in 2026 alone.
-
Philadelphia retired nurse: I’m saving tens of thousands thanks to a Harris-backed drug cap
Democrats are fighting to cap soaring prescription drug costs for Americans of all ages
-
Major drugmakers capped cost of asthma inhalers at $35 per month after investigation from Democrats
AstraZeneca, Boehringer Ingelheim, and GlaxoSmithKline all agreed to cap the price of asthma inhalers earlier this year following an investigation by a Democratic-led Senate Committee.
-
Opinion: To achieve gender equality, our state legislators must pass paid leave NOW
In this op-ed, Rachele Fortier, State Director of Family Friendly Pennsylvania, explains the importance of passing the Family Care Act to establish a bipartisan statewide paid family and medical leave program. This program is crucial for achieving gender equality, supporting mothers’ health, stabilizing the workforce, improving business productivity, and maintaining the state’s economic growth.

























